DNA Biomed Solns Tangible Net Worth Ratio
DNA Biomed Solns tangible net worth ratio. DNA Biomed Solns (DNA) has a Tangible Net Worth Ratio of 100.0% as of June 2025. This metric is calculated by deducting intangible assets (ILA0.00) from net assets (ILA98.23 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore DNA Biomed Solns (DNA) net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of DNA Biomed Solns (2005–2024)
Tangible net worth ratio of DNA Biomed Solns from 2005 to 2024. This chart shows how DNA Biomed Solns's Tangible Net Worth Ratio has changed across 13 annual periods from 2005 to 2024. As of June 2025, the ratio stands at 100.0%, reflecting net assets of ILA98.23 Million with intangible assets of ILA0.00 ILA. Check DNA strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
DNA Biomed Solns Tangible Net Worth Ratio by Year (2005–2024)
DNA Biomed Solns tangible net worth ratio by year from 2005 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for DNA Biomed Solns from 2005 to 2024, covering 13 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see DNA company net worth.
| Year | Tangible NW Ratio | Net Assets (ILA) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 100.0% | ILA101.47 Million | ILA0.00 | ILA104.28 Million | ▲ +0.0 pp |
| 2023 | 100.0% | ILA79.19 Million | ILA0.00 | ILA80.66 Million | ▲ +0.0 pp |
| 2022 | 100.0% | ILA80.11 Million | ILA0.00 | ILA81.99 Million | ▲ +0.0 pp |
| 2021 | 100.0% | ILA54.33 Million | ILA0.00 | ILA54.62 Million | ▲ +0.0 pp |
| 2020 | 100.0% | ILA7.95 Million | ILA0.00 | ILA18.49 Million | ▲ +0.0 pp |
| 2019 | 100.0% | ILA28.18 Million | ILA0.00 | ILA36.73 Million | ▲ +0.0 pp |
| 2018 | 100.0% | ILA64.90 Million | ILA0.00 | ILA80.72 Million | ▲ +0.0 pp |
| 2017 | 100.0% | ILA69.11 Million | ILA0.00 | ILA78.09 Million | ▲ +72.3 pp |
| 2013 | 27.7% | ILA11.49 Million | ILA8.30 Million | ILA20.68 Million | ▼ -0.2 pp |
| 2012 | 27.9% | ILA11.53 Million | ILA8.30 Million | ILA21.20 Million | ▲ +7.4 pp |
| 2011 | 20.5% | ILA10.45 Million | ILA8.30 Million | ILA16.82 Million | ▼ -79.5 pp |
| 2010 | 100.0% | ILA579.00K | ILA0.00 | ILA9.65 Million | ▲ +0.0 pp |
| 2005 | 100.0% | ILA3.26 Million | ILA0.00 | ILA6.48 Million | — |